Global Anticancer Drugs Market Research Report 2018

payment-methods
Secure Payment Methods

The Anticancer Drugs market research report from Marketresearchpro consolidates the most important industry information while highlighting essential and valuable data regarding the status quo and trajectory of the Anticancer Drugs industry with forecasts through next 5 years.

A management summary, key facts & figures, SWOT analysis and chief executive quotes on the latest developments in Anticancer Drugs industry provide a substantial introduction. The report additionally provides quantitative information regarding Anticancer Drugs industry financial numbers, selected key players and company details, as well as employee and salary data.

In the coming years, Anticancer Drugs market will continue to focus their efforts on product innovation in order to attract new consumers and keep existing consumers loyal to specific brands.

Below is the majority of the content covered in this report

  • Anticancer Drugs Product details, including pictures and technical specifications
  • Anticancer Drugs manufacturers, distributors and channels
  • Major players present in the Anticancer Drugs
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

The report covers the information pertaining to following geographies

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Additionally, the market is segmented by the following sectors

  • Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
  • Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
  • Hormonal Drugs

Please contact us if you are looking for any other possible breakdown across the products.

Not only this, figures covering the end user applications are also provided according to the following classification

  • Lung Cancer
  • Breast Cancer
  • Leukemia
  • Colorectal Cancer

In summary, the report serves to study and analyse the Anticancer Drugs size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anticancer Drugs, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • Global Anticancer Drugs Market Research Report 2018
  • 1 Anticancer Drugs Market Overview
    • 1.1 Product Overview and Scope of Anticancer Drugs
    • 1.2 Anticancer Drugs Segment by Type (Product Category)
      • 1.2.1 Global Anticancer Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
      • 1.2.2 Global Anticancer Drugs Production Market Share by Type (Product Category) in 2017
      • 1.2.3 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
      • 1.2.4 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
      • 1.2.5 Hormonal Drugs
    • 1.3 Global Anticancer Drugs Segment by Application
      • 1.3.1 Anticancer Drugs Consumption (Sales) Comparison by Application (2013-2025)
      • 1.3.2 Lung Cancer
      • 1.3.3 Breast Cancer
      • 1.3.4 Leukemia
      • 1.3.5 Colorectal Cancer
    • 1.4 Global Anticancer Drugs Market by Region (2013-2025)
      • 1.4.1 Global Anticancer Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
      • 1.4.2 North America Status and Prospect (2013-2025)
      • 1.4.3 Europe Status and Prospect (2013-2025)
      • 1.4.4 China Status and Prospect (2013-2025)
      • 1.4.5 Japan Status and Prospect (2013-2025)
      • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
      • 1.4.7 India Status and Prospect (2013-2025)
    • 1.5 Global Market Size (Value) of Anticancer Drugs (2013-2025)
      • 1.5.1 Global Anticancer Drugs Revenue Status and Outlook (2013-2025)
      • 1.5.2 Global Anticancer Drugs Capacity, Production Status and Outlook (2013-2025)
  • 2 Global Anticancer Drugs Market Competition by Manufacturers
    • 2.1 Global Anticancer Drugs Capacity, Production and Share by Manufacturers (2013-2018)
      • 2.1.1 Global Anticancer Drugs Capacity and Share by Manufacturers (2013-2018)
      • 2.1.2 Global Anticancer Drugs Production and Share by Manufacturers (2013-2018)
    • 2.2 Global Anticancer Drugs Revenue and Share by Manufacturers (2013-2018)
    • 2.3 Global Anticancer Drugs Average Price by Manufacturers (2013-2018)
    • 2.4 Manufacturers Anticancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
    • 2.5 Anticancer Drugs Market Competitive Situation and Trends
      • 2.5.1 Anticancer Drugs Market Concentration Rate
      • 2.5.2 Anticancer Drugs Market Share of Top 3 and Top 5 Manufacturers
      • 2.5.3 Mergers & Acquisitions, Expansion
  • 3 Global Anticancer Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
    • 3.1 Global Anticancer Drugs Capacity and Market Share by Region (2013-2018)
    • 3.2 Global Anticancer Drugs Production and Market Share by Region (2013-2018)
    • 3.3 Global Anticancer Drugs Revenue (Value) and Market Share by Region (2013-2018)
    • 3.4 Global Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.5 North America Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.6 Europe Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.7 China Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.8 Japan Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.9 Southeast Asia Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 3.10 India Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 4 Global Anticancer Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
    • 4.1 Global Anticancer Drugs Consumption by Region (2013-2018)
    • 4.2 North America Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
    • 4.3 Europe Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
    • 4.4 China Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
    • 4.5 Japan Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
    • 4.6 Southeast Asia Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
    • 4.7 India Anticancer Drugs Production, Consumption, Export, Import (2013-2018)
  • 5 Global Anticancer Drugs Production, Revenue (Value), Price Trend by Type
    • 5.1 Global Anticancer Drugs Production and Market Share by Type (2013-2018)
    • 5.2 Global Anticancer Drugs Revenue and Market Share by Type (2013-2018)
    • 5.3 Global Anticancer Drugs Price by Type (2013-2018)
    • 5.4 Global Anticancer Drugs Production Growth by Type (2013-2018)
  • 6 Global Anticancer Drugs Market Analysis by Application
    • 6.1 Global Anticancer Drugs Consumption and Market Share by Application (2013-2018)
    • 6.2 Global Anticancer Drugs Consumption Growth Rate by Application (2013-2018)
    • 6.3 Market Drivers and Opportunities
      • 6.3.1 Potential Applications
      • 6.3.2 Emerging Markets/Countries
  • 7 Global Anticancer Drugs Manufacturers Profiles/Analysis
    • 7.1 F. Hoffmann-La Roche Ltd
      • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.1.2 Anticancer Drugs Product Category, Application and Specification
        • 7.1.2.1 Product A
        • 7.1.2.2 Product B
      • 7.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.1.4 Main Business/Business Overview
    • 7.2 Eli Lilly and Company
      • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.2.2 Anticancer Drugs Product Category, Application and Specification
        • 7.2.2.1 Product A
        • 7.2.2.2 Product B
      • 7.2.3 Eli Lilly and Company Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.2.4 Main Business/Business Overview
    • 7.3 CELGENE CORPORATION
      • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.3.2 Anticancer Drugs Product Category, Application and Specification
        • 7.3.2.1 Product A
        • 7.3.2.2 Product B
      • 7.3.3 CELGENE CORPORATION Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.3.4 Main Business/Business Overview
    • 7.4 Novartis AG
      • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.4.2 Anticancer Drugs Product Category, Application and Specification
        • 7.4.2.1 Product A
        • 7.4.2.2 Product B
      • 7.4.3 Novartis AG Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.4.4 Main Business/Business Overview
    • 7.5 Pfizer Inc
      • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.5.2 Anticancer Drugs Product Category, Application and Specification
        • 7.5.2.1 Product A
        • 7.5.2.2 Product B
      • 7.5.3 Pfizer Inc Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
      • 7.5.4 Main Business/Business Overview
    • 7.6 Amgen Inc
      • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.6.2 Anticancer Drugs Product Category, Application and Specification
        • 7.6.2.1 Product A
        • 7.6.2.2 Product B
      • 7.6.3 Amgen Inc Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.6.4 Main Business/Business Overview
    • 7.7 Bayer AG
      • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.7.2 Anticancer Drugs Product Category, Application and Specification
        • 7.7.2.1 Product A
        • 7.7.2.2 Product B
      • 7.7.3 Bayer AG Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.7.4 Main Business/Business Overview
    • 7.8 AstraZeneca
      • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.8.2 Anticancer Drugs Product Category, Application and Specification
        • 7.8.2.1 Product A
        • 7.8.2.2 Product B
      • 7.8.3 AstraZeneca Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.8.4 Main Business/Business Overview
    • 7.9 Takeda Pharmaceutical Company Limited
      • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.9.2 Anticancer Drugs Product Category, Application and Specification
        • 7.9.2.1 Product A
        • 7.9.2.2 Product B
      • 7.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 7.9.4 Main Business/Business Overview
    • 7.10 Merck & Co.
      • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
      • 7.10.2 Anticancer Drugs Product Category, Application and Specification
        • 7.10.2.1 Product A
        • 7.10.2.2 Product B
      • 7.10.3 Merck & Co. Anticancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
      • 7.10.4 Main Business/Business Overview
  • 8 Anticancer Drugs Manufacturing Cost Analysis
    • 8.1 Anticancer Drugs Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Price Trend of Key Raw Materials
    • 8.1.3 Key Suppliers of Raw Materials
    • 8.1.4 Market Concentration Rate of Raw Materials
    • 8.2 Proportion of Manufacturing Cost Structure
    • 8.2.1 Raw Materials
    • 8.2.2 Labor Cost
    • 8.2.3 Manufacturing Expenses
    • 8.3 Manufacturing Process Analysis of Anticancer Drugs
  • 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    • 9.1 Anticancer Drugs Industrial Chain Analysis
    • 9.2 Upstream Raw Materials Sourcing
    • 9.3 Raw Materials Sources of Anticancer Drugs Major Manufacturers in 2017
    • 9.4 Downstream Buyers
  • 10 Marketing Strategy Analysis, Distributors/Traders
    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List
  • 11 Market Effect Factors Analysis
    • 11.1 Technology Progress/Risk
      • 11.1.1 Substitutes Threat
      • 11.1.2 Technology Progress in Related Industry
    • 11.2 Consumer Needs/Customer Preference Change
    • 11.3 Economic/Political Environmental Change
  • 12 Global Anticancer Drugs Market Forecast (2018-2025)
    • 12.1 Global Anticancer Drugs Capacity, Production, Revenue Forecast (2018-2025)
      • 12.1.1 Global Anticancer Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
      • 12.1.2 Global Anticancer Drugs Revenue and Growth Rate Forecast (2018-2025)
      • 12.1.3 Global Anticancer Drugs Price and Trend Forecast (2018-2025)
    • 12.2 Global Anticancer Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
      • 12.2.1 North America Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.2 Europe Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.3 China Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.4 Japan Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.5 Southeast Asia Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.2.6 India Anticancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.3 Global Anticancer Drugs Production, Revenue and Price Forecast by Type (2018-2025)
    • 12.4 Global Anticancer Drugs Consumption Forecast by Application (2018-2025)
  • 13 Research Findings and Conclusion
  • 14 Appendix
    • 14.1 Methodology/Research Approach
      • 14.1.1 Research Programs/Design
      • 14.1.2 Market Size Estimation
      • 14.1.3 Market Breakdown and Data Triangulation
    • 14.2 Data Source
      • 14.2.1 Secondary Sources
      • 14.2.2 Primary Sources
    • 14.3 Disclaimer

Request a FREE Sample


PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers

Request a FREE Sample